| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.088 | 0.2 |